FDA Panel Votes to Recommend Pfizer-BioNTech COVID-19 Vaccine in Children 5 to 11 Years of Age
October 27th 2021No timetable was set for the FDA to decide on an official EUA designation for the Pfizer-BioNTech vaccine in children 5 to 11 years of age, however a decision is expected within the next few days.
Read More
Overview of Burkitt Lymphoma, the Patient Populations Most Impacted
October 25th 2021Adam Olszewski, MD, associate professor of medicine in Alpert Medical School at Brown University, discusses his SOHO 2021 conference presentation on prognostication and treatment of Burkitt lymphoma in the modern era.
Watch
FDA Approves PD-L1 Test To Evaluate Patients With NSCLC Eligible to Receive Atezolizumab
October 25th 2021Officials with the FDA have approved Roche’s VENTANA PD-L1 (SP263) Assay as a diagnostic test to evaluate patients with non-small cell lung cancer (NSCLC) who are eligible to receive atezolizumab (Tecentriq, Genentech).
Read More